Nifty 50 closed at 23,405.6, down 0.3% on the day, and remains below its 200-day average — sitting 11.1% under its 52-week high. The overall regime is weak but recovering, now in its second day of that read, with the near-term signal neutral-to-up. Decliners led advancers 1,312 to 908, so the tape is narrow, but the underlying structure is quietly improving: 136 stocks posted 52-week highs against 89 new lows, and 16 golden crosses registered versus just 2 death crosses.
Breadth and Stage-2 picture
Only 33.7% of NSE stocks sit above their 200-day average, though 56.6% are above their 50-day and 38.3% above their 20-day — a profile consistent with a market that has bounced off lows but has not yet reclaimed broad participation. The Stage-2 advancing cohort now stands at 21.3% of the universe, and the trend is constructive: it has widened by 3.6 over the last 5 days, 7.8 over 20 days, and 8.2 over 60 days. Reinforcing that, 75 stocks moved from Stage 1 basing into Stage 2 advancing over the last five sessions, against just 4 moving the other way into Stage 3 topping — a net of 71 fresh entrants into the advancing stage. Consumer Staples, Utilities and Information Technology are the sectors where the Stage-2 cohort is expanding fastest right now.
Sector rotation and standout movers
On the day, Health Care and Communication Services each edged up 0.5%, with Consumer Discretionary adding 0.3% — modest gains, but they sit atop the one-month and three-month rankings as well. Communication Services leads the one-month table at +5%, Health Care follows at +3.8%, and over three months Industrials is the strongest sector at +9.7%, with Health Care at +7.9% and Communication Services at +6%. Financials and Energy remain the three-month laggards at -11.6% and -7.2% respectively. Among today's high-volume standouts, Savita Oil Technologies moved 17.6% on volume running at 41.2 times its average, while Emkay Global Financial Services rose 20% on 25.8 times normal volume — both flagged by the screener purely on the basis of price and volume expansion, not as actionable calls.
What cleared the screen today
Eight stocks registered fresh breakouts in today's scan. Zydus Lifesciences carries the highest setup score of the group at 8.3, screening from Health Care — the sector that has held up best across all three time frames. V2 Retail cleared at 7.7 from Consumer Discretionary, and Gandhar Oil Refinery came through at 7.5 from Energy, notable given that sector's three-month underperformance. Among sustained setups — stocks that have held clean Stage-2 structure over multiple sessions — Stylam Industries leads at a setup score of 9.8, followed by Avalon Technologies at 9.6 and Bliss GVS Pharma at 9.6. The full breakout and transition tables are below.
| Stock | Sector | Setup | % 1D |
|---|---|---|---|
| Zydus Lifesciences Ltd | Health Care | 8.3 | -0.2% |
| V2 Retail Ltd | Consumer Discretionary | 7.7 | +2.2% |
| Gandhar Oil Refinery (INDIA) Ltd | Energy | 7.5 | +0.9% |
| Artemis Medicare Services Ltd | Industrials | 7.3 | -0.9% |
| BLS E-Services Ltd | Information Technology | 7.2 | +0.4% |
| Chembond Chemicals Ltd | Materials | 6.6 | -0.6% |
| Niva Bupa Health Insurance Company Ltd | Financials | 6.5 | 0.0% |
| Pondy Oxides and Chemicals Ltd | Materials | 6.4 | -1.6% |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Health Care | +0.5% | +3.8% | +7.9% | 71 | 29% |
| Communication Services | +0.5% | +5.0% | +6.0% | 65 | 11% |
| Consumer Discretionary | +0.3% | -0.4% | -1.7% | 65 | 18% |
| Financials | +0.2% | -5.6% | -11.6% | 57 | 18% |
| Energy | +0.0% | -7.7% | -7.2% | 62 | 36% |
| Industrials | -0.1% | +1.6% | +9.7% | 68 | 23% |
| Materials | -0.2% | +2.3% | +5.1% | 72 | 23% |
| Utilities | -0.4% | -1.0% | +5.5% | 64 | 26% |
| Consumer Staples | -0.7% | -5.4% | -4.4% | 52 | 30% |
| Real Estate | -1.4% | -4.2% | -3.6% | 42 | 7% |
| Information Technology | -4.4% | +1.0% | -0.1% | 41 | 18% |
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.